Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,811 | 12,821 | 12,525 | 23,420 | 33,689 |
| Receivables | 76,919 | 60,427 | 55,512 | 48,943 | 20,475 |
| Inventories | 8,650 | 7,474 | 6,253 | 5,108 | 2,616 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 821 |
| Other current assets | 561 | 1,001 | 4,535 | 4,889 | 1,141 |
| TOTAL | $103,668 | $85,875 | $78,825 | $82,360 | $58,742 |
| Non-Current Assets | |||||
| PPE Net | 60,888 | 36,504 | 34,036 | 34,577 | 15,082 |
| Intangibles | 337,921 | 221,184 | 224,083 | 234,221 | 7,141 |
| Other Non-Current Assets | 2,538 | 891 | 174 | 129 | 141 |
| TOTAL | $401,347 | $258,579 | $258,293 | $268,927 | $22,364 |
| Total Assets | $505,015 | $344,454 | $337,118 | $351,287 | $81,106 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,873 | 3,799 | 3,842 | 9,469 | 66 |
| Accounts payable and accrued liabilities | 17,779 | 10,450 | 16,782 | 12,464 | 6,294 |
| Accrued Expenses | 28,048 | 15,626 | 12,598 | 13,591 | 5,105 |
| Other current liabilities | 927 | 1,406 | N/A | N/A | N/A |
| TOTAL | $60,925 | $36,471 | $38,113 | $40,058 | $14,623 |
| Non-Current Liabilities | |||||
| Long Term Debt | 92,880 | 91,152 | 92,058 | 52,336 | 64 |
| Other Non-Current Liabilities | 3,060 | 32,898 | 22,873 | 28,602 | 0 |
| TOTAL | $123,647 | $136,021 | $135,282 | $101,719 | $6,078 |
| Total Liabilities | $184,572 | $172,492 | $173,395 | $141,777 | $20,701 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,566 | 80,507 | 78,823 | 75,864 | 60,256 |
| Common Shares | 94 | 80 | 79 | 76 | 60 |
| Retained earnings | -19,363 | -58,422 | -52,460 | -22,063 | -19,406 |
| Other shareholders' equity | -579 | 274 | 0 | 0 | 0 |
| TOTAL | $320,443 | $171,962 | $163,723 | $209,510 | $60,405 |
| Total Liabilities And Equity | $505,015 | $344,454 | $337,118 | $351,287 | $81,106 |